Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick T McGann

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Paediatrics and International Child Health|January 9, 2016
Improving survival for children with sickle cell disease: newborn screening is only the first stepPatrick T McGann
Pediatrics|June 1, 2016
Time to Invest in Sickle Cell Anemia as a Global Health PriorityPatrick T McGann
Blood|April 9, 2016
Hydroxyurea for abnormal TCDs: safe to switch?Patrick T McGann
The Journal of Pediatrics|March 18, 2014
Sickle cell anemia: an underappreciated and unaddressed contributor to global childhood mortalityPatrick T McGann
Clinical Pharmacology and Therapeutics|September 2, 2020
Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision MedicineMin Dong, Patrick T McGann
British Journal of Haematology|August 2, 2021
Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell diseaseDaniel Dexter, Patrick T McGann
Pediatric Blood & Cancer|September 22, 2021
How I approach disease-modifying therapy in children with sickle cell disease in an era of novel therapiesKristine Karkoska, Patrick T McGann
Blood Cells, Molecules & Diseases|August 29, 2017
The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologiesPatrick T McGann, Carolyn Hoppe
Pharmacotherapy|March 12, 2023
Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challengesDaniel Dexter, Patrick T McGann
British Journal of Haematology|November 6, 2024
Sickle cell disease in India: Not just a mild conditionManpreet Kochhar, Patrick T McGann
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Paediatrics and International Child Health|January 9, 2016
Improving survival for children with sickle cell disease: newborn screening is only the first stepPatrick T McGann
Pediatrics|June 1, 2016
Time to Invest in Sickle Cell Anemia as a Global Health PriorityPatrick T McGann
Blood|April 9, 2016
Hydroxyurea for abnormal TCDs: safe to switch?Patrick T McGann
The Journal of Pediatrics|March 18, 2014
Sickle cell anemia: an underappreciated and unaddressed contributor to global childhood mortalityPatrick T McGann
Clinical Pharmacology and Therapeutics|September 2, 2020
Changing the Clinical Paradigm of Hydroxyurea Treatment for Sickle Cell Anemia Through Precision MedicineMin Dong, Patrick T McGann
British Journal of Haematology|August 2, 2021
Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell diseaseDaniel Dexter, Patrick T McGann
Pediatric Blood & Cancer|September 22, 2021
How I approach disease-modifying therapy in children with sickle cell disease in an era of novel therapiesKristine Karkoska, Patrick T McGann
Blood Cells, Molecules & Diseases|August 29, 2017
The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologiesPatrick T McGann, Carolyn Hoppe
Pharmacotherapy|March 12, 2023
Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challengesDaniel Dexter, Patrick T McGann
British Journal of Haematology|November 6, 2024
Sickle cell disease in India: Not just a mild conditionManpreet Kochhar, Patrick T McGann
Pageof 11